Celgene Corp (NASDAQ:CELG)

CAPS Rating: 5 out of 5

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

Results 1 - 20 of 235 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

1
Member Avatar afketter (88.12) Submitted: 5/7/2014 10:05:17 PM : Outperform Start Price: $72.49 CELG Score: +22.53

Celgene has been brought down due to the whole biotech sector dropping, but they have solid earnings and are cheap on a 2016 basis. Not all of biotech will recover, but CELG will be one that moves a lot higher in the next 2 years

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 5/7/2014 6:06:11 PM : Underperform Start Price: $87.26 CELG Score: -6.61

Biotech bull market top

Recs

0
Member Avatar TerryFool (< 20) Submitted: 4/21/2014 8:05:51 AM : Outperform Start Price: $69.58 CELG Score: +28.15

INVEST BUY@ 140 TP 193 CAPS 4

Recs

1
Member Avatar awallejr (81.55) Submitted: 4/10/2014 5:18:40 PM : Outperform Start Price: $68.46 CELG Score: +26.92

Might be a little early but oversold.

Recs

0
Member Avatar ShoreDoc (65.00) Submitted: 4/9/2014 4:12:55 PM : Outperform Start Price: $73.86 CELG Score: +19.80

pipeline, valuation

Recs

0
Member Avatar DrGoldin (99.71) Submitted: 3/29/2014 2:25:12 AM : Outperform Start Price: $57.33 CELG Score: +37.59

The annihilation of Celgene continues, and a few years down the road people are going to wonder what on earth investors were thinking in March of 2014. Sitting tight with this one.

Recs

0
Member Avatar jbond009 (42.97) Submitted: 3/25/2014 8:24:38 PM : Outperform Start Price: $72.86 CELG Score: +21.50

Extremely oversold, very low P/E ratio

Recs

0
Member Avatar Chemdawg (31.59) Submitted: 3/7/2014 2:09:37 AM : Outperform Start Price: $79.06 CELG Score: +12.44

lots of old people in this country ...plus obama care

Recs

0
Member Avatar herodotous (< 20) Submitted: 2/4/2014 1:59:44 AM : Outperform Start Price: $74.54 CELG Score: +11.19

Excellent pipeline and prospects for continued growth.

Recs

0
Member Avatar klarcbarr (36.27) Submitted: 1/15/2014 5:25:47 AM : Outperform Start Price: $83.90 CELG Score: +2.84

The company inspires overall confidence through process and innovation. The blazing track record and robust pipeline forces me to conclude this one is a no-brainer.

Recs

0
Member Avatar gypsystem (46.72) Submitted: 1/11/2014 12:47:38 AM : Outperform Start Price: $85.24 CELG Score: +0.86

Great pipeline

Recs

0
Member Avatar Flygal5 (99.27) Submitted: 12/6/2013 11:23:41 AM : Outperform Start Price: $82.69 CELG Score: +2.32

new effective medications for cancers

Recs

0
Member Avatar 1stPrincipleFool (37.43) Submitted: 11/20/2013 6:51:14 PM : Outperform Start Price: $78.09 CELG Score: +8.04

growind demand

Recs

0
Member Avatar megamill (< 20) Submitted: 10/30/2013 9:12:24 PM : Outperform Start Price: $75.89 CELG Score: +9.72

Great list of drugs in the pipe line, along with their specialty areas.

Recs

0
Member Avatar pa1vette (52.12) Submitted: 10/25/2013 4:25:40 PM : Outperform Start Price: $78.00 CELG Score: +6.22

celg

Recs

0
Member Avatar 2trpop (93.94) Submitted: 10/18/2013 2:57:59 PM : Outperform Start Price: $79.99 CELG Score: +2.17

fstg experiment

Recs

0
Member Avatar HealthyMoney (< 20) Submitted: 10/15/2013 6:16:22 PM : Outperform Start Price: $78.03 CELG Score: +2.71

Revlimid label expansion will supply the underlying revenue base. Apremilast approval could help Celgene carve some market share in the huge anti-inflammatory market dominated by injectable blockbusters.

Recs

0
Member Avatar MakeMoney2013 (27.87) Submitted: 10/8/2013 7:38:47 AM : Outperform Start Price: $77.24 CELG Score: +1.62

going with a cramer hunch

Recs

0
Member Avatar kevrose31 (83.79) Submitted: 9/14/2013 7:20:45 PM : Outperform Start Price: $75.40 CELG Score: +7.21

They might as well be printing money.

Recs

0
Member Avatar highgrowthcarson (40.07) Submitted: 9/7/2013 9:09:17 PM : Outperform Start Price: $73.98 CELG Score: +6.46

Great pipeline. Seems to have the best scientists of any major biotech. Seems to be laser focused. However biotech not my speciality and this is simply my best pick in the sector based on information available to anyone. So far has worked out.

Featured Broker Partners


Advertisement